Pretty standard operating procedure for the company, like Oncolix, owning the patents, product(s), in charge of processes, etc, to control flow of information. No surprise there. Biotech financiers are there for the ROI, not accolades every time news comes out.
Giddyup AEPP/ONCX!!!